We comparatively analyzed serially autopsied, elderly Japanese patients (n 5 2205) with pancreatic intraepithelial neoplasias (PanINs) and pancreatic ductal adenocarcinomas (PDACs) on the basis of their pancreatic lesions, clinical information, and single nucleotide polymorphisms (SNPs). The incidence of PanIN-1, 22, 23, and PDACs in these patients was 55%, 12%, 1.4%, and 2.4%, respectively. The occurrence of PanINs was associated with female sex, increasing age, and lower body mass index. We did not identify any common SNPs between PanINs and PDACs. There were no common SNPs associated with PanINs and PDACs between men and women. In previously reported pancreatic cancer-associated SNPs, rs3790844 (NR5A2) showed a significant correlation with PDAC in our cohort. Six SNPs (rs7016880, rs10096633, rs10503669, rs12678919, rs17482753, rs328) that were correlated with blood lipid levels were associated with the risk for PDACs. Our data suggest that different clinicopathological characteristics and predispositions may affect pancreatic carcinogenesis in elderly Japanese patients.
| I N TR ODU C TI ONMorbidity and mortality due to pancreatic cancers have been increasing worldwide. 1,2 In Japan, pancreatic cancer represents the fifth and the fourth leading cause of cancer-related deaths in men and women, respectively. Tobacco use, 3 heavy alcohol consumption, diabetes, obesity, pancreatitis, low 25-(OH) vitamin D levels due to low exposure to solar radiation, and aging are known to be risk factors for pancreatic cancer. 4,5 Studies on autopsied patients, surgically resected tissue specimens, and recent molecular studies have shown that pancreatic cancer does not arise de novo; it progresses through a multistep process involving either intraepithelial proliferation or through a dysplasiacancer sequence. [6][7][8] The vast majority of pancreatic cancers are thought to arise from pancreatic intraepithelial neoplasias (PanINs); high-grade PanINs (carcinomas in situ) are believed to be immediate precursors of pancreatic ductal adenocarcinomas (PDACs), which are the most common type of pancreatic cancers. 9 Mutations in KRAS, CDKN2A, TP53, and SMAD4